ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00752570
Recruitment Status : Completed
First Posted : September 15, 2008
Last Update Posted : September 2, 2015
Sponsor:
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2010
  Actual Study Completion Date : June 2012
  Certification/Extension First Submitted : July 13, 2015